Today: 11 June 2026
Visa stock drops 4.5% after Mexico blocks Prosa deal — what Wall Street watches next
23 February 2026
2 mins read

Visa stock drops 4.5% after Mexico blocks Prosa deal — what Wall Street watches next

New York, Feb 23, 2026, 15:58 EST — Regular session.

  • Visa shares dropped roughly 4.5% in late afternoon, tracking losses across U.S. financials.
  • Visa’s bid to acquire a 51% stake in Mexican payments processor Prosa hit a wall after the country’s antitrust commission shot down the deal.
  • Investors eye Visa’s plans for Mexico, along with its scheduled appearance at an investor conference on March 3.

Visa Inc (V) dropped 4.5% to $306.64 late Monday, echoing losses across U.S. financials. Shares kicked off at $317.09, then dipped as low as $304.97 during the session.

Visa had billed the Prosa stake as a chance to dig further into Mexico. That looks uncertain again after the outright rejection, leaving its regional strategy unresolved. All this hit just as trade and inflation headlines shook up risk appetite, sending major financial stocks lower.

Visa’s bid to buy a 51% stake in Prosa has been blocked by Mexico’s National Antitrust Commission, according to a Zacks update on Nasdaq.com. Regulators flagged fears over too much market power and the potential exposure of sensitive data. Visa had aimed to combine its network with Prosa’s Carnet platform, a move that would have handed it sway over two of Mexico’s four main card-payment clearinghouses — the backbone for transaction routing and settlement.

The commission said the deal might take out a direct rival, since Visa already handles its own processing in the country, and could hurt Carnet’s standing as a cheaper card alternative, according to El Financiero. Prosa is responsible for processing over 10 billion transactions each year, the outlet noted, with shareholders including Banorte, HSBC Mexico, Santander Mexico, and Scotiabank Mexico.

Visa called the decision “disappointing” and said it’s weighing its next steps. In a statement, the firm argued, “We firmly believe that the combination of Visa and Prosa would significantly accelerate competition in the market.” Visa Corporate

Visa’s push into Latin America hit a snag in Mexico, but the company isn’t letting up. Just last week, it inked an agreement to acquire Prisma and Newpay, two payment platforms owned by Advent International, aiming to strengthen its position in Argentina. Reuters says that deal should wrap up in the first quarter of 2026.

Visa slid along with broader U.S. stocks, rattled by a Supreme Court decision on tariffs and fresh trade threats from President Donald Trump that stirred up fears about shifting policies. “This adds a level of uncertainty because it calls into question the trade deals that have been made,” said Ross Mayfield, investment strategy analyst at Baird. Reuters

Other payments stocks took a hit as well. Mastercard dropped roughly 6.3%, American Express slid 7.3%. PayPal, on the other hand, climbed 5.5%.

This story isn’t settled yet. A resolution in Mexico could help Visa move past the Prosa setback, while tougher rules or fee caps from regulators would keep pressure on the shares. Both Visa and Mastercard are still working to wrap up the new U.S. merchant “swipe fee” settlement — those interchange charges that tend to resurface in regulatory debates. Reuters

Macro watchers are zeroed in on inflation data and rate forecasts, scanning for signals on consumer appetite and international travel—both critical for card network performance. The U.S. producer price index for January drops at 8:30 a.m. ET on Friday, Feb. 27, the Labor Department says on its release calendar.

Visa’s Chief Product and Strategy Officer Jack Forestell is slated for a speaking slot at the Morgan Stanley Technology, Media & Telecom Conference on March 3, according to Visa. Market players will be listening for any remarks on Mexico or hints about the company’s approach to dealmaking going forward.

Stock Market Today

  • S&P 500, Dow, Nasdaq Drop Amid Middle East Tensions and Rising Oil Prices
    June 10, 2026, 6:45 PM EDT. U.S. stock indexes plunged sharply on Wednesday as escalating tensions between the U.S. and Iran in the Middle East drove crude oil prices up over 2%. The S&P 500 fell 1.62%, Dow Jones Industrial Average lost 1.87% hitting a 2.5-week low, and Nasdaq 100 dropped 1.98%. Key sectors including chipmakers, AI infrastructure, and major tech stocks retreated, adding pressure to markets. Airlines and trucking stocks declined as rising oil costs and Amazon's freight expansion impacted their outlooks. Despite these declines, May U.S. consumer price data aligned with expectations, providing some market support. Oil surged above 2% following U.S. airstrikes on Iranian defenses and subsequent Iranian missile and drone attacks, raising concerns over Strait of Hormuz shipping routes and global energy supplies.

Latest articles

Navan Shares Rally, Pushing NAVN Close to IPO Mark on Upbeat Outlook

Navan Shares Rally, Pushing NAVN Close to IPO Mark on Upbeat Outlook

11 June 2026
Navan shares surged over 18% after hours as the company raised its fiscal 2027 revenue growth outlook to 30% from 24%, following a 40% revenue jump to $220.2 million and a 50% surge in gross booking volume to $3.1 billion, beating Wall Street estimates and fueled by strong enterprise travel demand and AI-driven tools.
Intel Drops as Chip Selloff Hits Shares Despite Google AI Bid Hopes

Intel Drops as Chip Selloff Hits Shares Despite Google AI Bid Hopes

11 June 2026
Intel shares fell 0.8% to $107.04 as the stock’s main catalyst—a reported Google order for over 3 million Intel-made TPUs for 2028—remains unconfirmed, while the Philadelphia Semiconductor Index plunged 3.6% and tech stocks entered correction territory, highlighting investor focus on external foundry demand amid sector-wide profit-taking and supply chain concerns.
CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares
Previous Story

CrowdStrike stock steadies premarket after Anthropic’s Claude Code Security rattles cyber shares

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Next Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Go toTop